b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29529501</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>04</Month>\n            <Day>26</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>04</Month>\n            <Day>26</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1768-3254</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>150</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Apr</Month>\n                        <Day>25</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>European journal of medicinal chemistry</Title>\n                <ISOAbbreviation>Eur J Med Chem</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>206-227</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0223-5234(18)30242-3</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmech.2018.03.007</ELocationID>\n            <Abstract>\n                <AbstractText>HIV infection still has a serious health and socio-economical impact and is one of the primary causes of morbidity and mortality all over the world. HIV infection and the AIDS pandemic are still matters of great concern, especially in less developed countries where the access to highly active antiretroviral therapy (HAART) is limited. Patient compliance is another serious drawback. Nowadays, HAART is the treatment of choice although it is not the panacea. Despite the fact that it suppresses viral replication at undetectable viral loads and prevents progression of HIV infection into AIDS HAART has several pitfalls, namely, long-term side-effects, drug resistance development, emergence of drug-resistant viruses, low compliance and the intolerance of some patients to these drugs. Moreover, another serious health concern is the event of co-infection with more than one pathogen at the same time (e.g. HIV and HCV, HBV, herpes viruses, etc). Currently, the multi-target drug approach has become an exciting strategy to address complex diseases and overcome drug resistance development. Such multifunctional molecules combine in their structure pharmacophores that may simultaneously interfere with multiple targets and their use may eventually be more safe and efficacious than that involving a mixture of separate molecules because of avoidance or delay of drug resistance, lower incidence of unwanted drug-drug interactions and improved compliance. In this review we focus on multifunctional molecules with dual activity against different targets of the HIV life cycle or able to block replication, not only of HIV but also of other viruses that are often co-pathogens of HIV. The different approaches are documented by selected examples.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>de Castro</LastName>\n                    <ForeName>Sonia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto de Qu\xc3\xadmica M\xc3\xa9dica (IQM, CSIC) Juan de La Cierva 3, E-28006 Madrid, Spain.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Camarasa</LastName>\n                    <ForeName>Mar\xc3\xada-Jos\xc3\xa9</ForeName>\n                    <Initials>MJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto de Qu\xc3\xadmica M\xc3\xa9dica (IQM, CSIC) Juan de La Cierva 3, E-28006 Madrid, Spain. Electronic address: mj.camarasa@iqm.csic.es.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016454">Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>03</Month>\n                <Day>05</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>France</Country>\n            <MedlineTA>Eur J Med Chem</MedlineTA>\n            <NlmUniqueID>0420510</NlmUniqueID>\n            <ISSNLinking>0223-5234</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006678" MajorTopicYN="N">HIV</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D064798" MajorTopicYN="N">Polypharmacology</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Co-infection</Keyword>\n            <Keyword MajorTopicYN="N">Dual drugs</Keyword>\n            <Keyword MajorTopicYN="N">HIV</Keyword>\n            <Keyword MajorTopicYN="N">Hybrids</Keyword>\n            <Keyword MajorTopicYN="N">Multi-target drugs</Keyword>\n            <Keyword MajorTopicYN="N">Polypharmacology</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>02</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>03</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>3</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>4</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>3</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29529501</ArticleId>\n            <ArticleId IdType="pii">S0223-5234(18)30242-3</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ejmech.2018.03.007</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'